A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may sharply boost one-year progression-free survival for people with aggressive lymphoma.
In just a few years,…
Category: 6. Business
-
Oil steadies, Ukraine peace talks and US rate decision in spotlight – Reuters
- Oil steadies, Ukraine peace talks and US rate decision in spotlight Reuters
- Oil Steady After Biggest Drop in Three Weeks With Glut in Focus Bloomberg.com
- Iraq’s Massive West Qurna 2 Field Resumes Oil Flows After Brief Outage Crude Oil Prices…
Continue Reading
-
Pepsi to cut product offering nearly 20% in deal with $4 billion activist Elliott
PepsiCo plans to cut prices and eliminate some of its products under a deal with an activist investor announced Monday.
The Purchase, New York-based company, which makes Cheetos, Tostitos and other Frito-Lay products as well as beverages, said…
Continue Reading
-
Cursor internal AI Help Desk handles 80% of employees’ support tickets
AI coding-assistant start-up Cursor isn’t just using artificial intelligence to help developers write code, it’s deploying AI across its own internal operations, CEO, Michael Truell, told the audience at Fortune’s Brainstorm AI in San…
Continue Reading
-
Pre-Budget shopper ‘jitters’ dampen Black Friday sales
Pre-Budget “jitters” among shoppers dampened a much-needed Black Friday boost for retailers, figures show.
Total retail sales across the UK increased by 1.4% year on year in November – the weakest growth in six months despite elevated…
Continue Reading
-
“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List – Biogen
- “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List Biogen
- Eli Lilly’s Mounjaro added to China’s state insurance list for diabetes treatment Reuters
- Eli…
Continue Reading
-
Glean hits $200 million ARR, up from $100 million nine months back
Glean, last valued at $7.2 billion, has hit $200 million in annual recurring revenue, CEO Arvind Jain revealed at Fortune Brainstorm AI San Francisco.
“What’s driving all of this is the awareness from CEOs and executives that this is the…
Continue Reading
-
Utilities Down as Treasury Yields Rise – Utilities Roundup
Shares of power producers fell as Treasury yields rose ahead of the Federal Reserve meeting.
“Traditionally, most of the time, we don’t think of utilities as being in the growth camp, but right now they certainly are,” said J.D. Joyce,…
Continue Reading
-
Alexander & Baldwin to be Taken Private in $2.3 Billion Transaction
Shareholders to Receive $21.20 Per Share in Cash Representing a 40.0% Premium to Closing Price on December 8, 2025
HONOLULU – Alexander & Baldwin, Inc., (NYSE: ALEX) ( “A&B” or the “Company”), a Hawaiʻi-based owner,…
Continue Reading
-
Utilities Trust of Australia acquires Ontario Teachers’ majority stake in Sydney Desalination Plant
- Utilities Trust of Australia (UTA) has acquired an additional 60% stake from Ontario Teachers’ Pension Plan (Ontario Teachers’) to take full ownership of the asset
- UTA and Ontario Teachers’ have co-owned the asset since 2012
SYDNEY /…
Continue Reading